Alpha-1-antitrypsin levels and prevalence of Pi variant phenotypes in adult Nigerian asthmatics

Abstract

Alpha-1-antitrypsin (MAT) phenotypes and serum levels were determined in 99 asth-matic patients and 100 control subjects. The phenotypes encountered were PiMM 74% in asthmatics, 98% in controls; PiMZ 19% in asthmatics, 1% in controls; PiMW 3% in asth-matics, 0% in controls; and PiLM 2% in asthmatics, 1% in controls. There was one asthmatic patient with the homozygous de-ficient phenotype ZZ. The result revealed that there were more deficient heterozygous phenotypes in the asthmatic group than the control group. I here was also a positive cor-relation between the number of patients with deficient phenotypes and the severity of asthma (P < 0.02). Analysis of the serum A1 AT levels revealed that as a group the asthmatic patients had significantly lower A1AT levels (1.97 ± 0.18 g/1) than the control group (2.21 ± 0.15 g/1) (P < 0.01). However, there was no statistically significant difference in the A1AT serum levels of patients with PIMM phenotype and the control of the same phenotype. Statistical analysis could not be done for the other phenotypes because of the small number of subjects. Apart from the patient with PiZZ the A1AT serum levels encountered in the study were not low enough to justify replacement therapy with alpha-1-proteinase inhibitor in our asthmatic patients